CLEARLAB CONTACT LENSES AND LENS CARE PRODUCTS RECEIVE COMBINED MDSAP, ISO13485 AND EU MDR CERTIFICATION FROM DNV
Parallel audit streamlines certification and speeds up access to global markets SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- DNV, the independent global assurance and risk management provider, has certified contact lenses and multi-purpose lens care...
SeeTrue AI screening solution becomes the first and only to receive ECAC certification for Automated Prohibited Items Detection (APIDS)
ECAC's recognition marks a major leap towards automated, regulatory-approved screening operations. TEL AVIV, Israel, Jan. 8, 2026 /PRNewswire/ -- SeeTrue AI, a global leader in AI-powered security screening, is proud to announce that its SeeTrue...
MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan
- South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM® targeting the Japanese knee osteoarthritis market. SEOUL, South Korea, Dec. 19, 2025 /PRNewswire/ -- MEDIPOST...
Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio today announced Formation Bio's acquisition of worldwide rights, excluding...
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Fosun Pharma (SSE: 600196; HKEX: 02196) today announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited. ("Yao Pharma"), Shanghai Fosun Pharmaceutical Industrial Development Company...
XPOVIO® Approved in Hong Kong for Two Additional Indications in Multiple Myeloma and Diffuse Large B-Cell Lymphoma
- XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the treatment for multiple myeloma (MM) when used together with dexamethasone (Xd), and its recent approvals as a monotherapy for...
Suunto Elevates Your Black Friday Adventure with Unforgettable Deals on Watches and Gear
SYDNEY, Nov. 20, 2025 /PRNewswire/ -- Suunto, a leading innovator in sports wearables, announced today several exclusive Black Friday deals on its latest watches, headphones and accessories. From November 20 to December 1, customers can save on...
GCash launches Virtual US Account, revolutionizing how Filipinos receive USD payments and remittances
MANILA, Philippines, Nov. 8, 2025 /PRNewswire/ -- The Philippines' leading finance super app, GCash, has introduced a new game-changing product on November 5, 2025 — the GCash Virtual US Account, which enables Filipinos to receive payments and...
Tencent's CarbonX Program 2.0 Identifies 50 Global Finalists in Race to Scale Climate Solutions
SHENZHEN, China, Oct. 29, 2025 /PRNewswire/ -- Tencent (0700.HK) today announced the top 50 finalists, coming from 12 countries and regions around the world, for its CarbonX Program 2.0 (CarbonX 2.0), a landmark initiative to accelerate next...
CGTN: China-U.S. trade talks in London receive positive market reception
With the first meeting of the China-U.S. economic and trade consultation mechanism set to continue in London on Tuesday, CGTN publishes an article discussing the significance of the highly anticipated talks and the global expectations surrounding...